Table 5. Comparison of OS and PFS in OMC compared to serous ovarian carcinoma.
| Study | Median OS (mon) | Median PFS (mon) | |
|---|---|---|---|
| Winter et al. [47] | |||
| Serous | 45.1 | 16.9 | |
| Mucinous | 14.8 | 10.5 | |
| Alexandre et al. [48] | |||
| Serous | 47.2 | 17.5 | |
| Mucinous | 21.6 | 11.4 | |
| Tian et al. [49] | |||
| Serous | 40.5 | 16.7 | |
| Mucinous | 11.3 | 9.7 | |
| Mackay et al. [50] | |||
| Serous | 40.8 | 16.1 | |
| Mucinous | 14.6 | 7.6 | |
OMC, ovarian mucinous carcinoma; OS, overall survival; PFS, progression-free survival.